Boerrigter Guido, Hocher Berthold, Lapp Harald
HELIOS Klinikum Erfurt, Nordhäuser Str. 74, 99089, Erfurt, Germany,
Curr Heart Fail Rep. 2013 Dec;10(4):285-95. doi: 10.1007/s11897-013-0170-8.
Both cardiovascular and renal diseases are common and frequently coexist in the same patient. Indeed, renal dysfunction has been shown to be a more powerful independent predictor of poor outcomes in heart failure (HF) than left ventricular ejection fraction or functional class. Furthermore, acute kidney injury is a frequent therapeutic concern in heart failure. Consequently, there has been much interest in developing new renoprotective treatments and novel biomarkers to monitor renal function. Additionally, given the crucial cardiorenal interaction and interdependence, the concept of a cardiorenal syndrome with five different subtypes has been advanced to better categorize patients and facilitate research.
心血管疾病和肾脏疾病都很常见,且经常在同一患者中共存。事实上,肾功能不全已被证明是心力衰竭(HF)患者预后不良的一个比左心室射血分数或心功能分级更强有力的独立预测因素。此外,急性肾损伤是心力衰竭治疗中经常关注的问题。因此,人们对开发新的肾脏保护治疗方法和新型生物标志物来监测肾功能产生了浓厚兴趣。此外,鉴于心脏和肾脏之间至关重要的相互作用和相互依存关系,一种具有五种不同亚型的心肾综合征概念已被提出,以便更好地对患者进行分类并促进研究。